Amid FDA chaos, approval of a rare disease drug gets delayed — again
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly…
M42 and Juvenescence collaborate on AI-enabled longevity drugs
Abu Dhabi biotech collaboration aims to fast-track clinical-stage therapies that target the root mechanisms of aging and age-related…
D-Wave Quantum and Japanese pharma use quantum computing in drug discovery process
D-Wave Quantum Inc. (NYSE: QBTS) and the pharmaceutical division of Japan Tobacco Inc. (JT) finished a joint proof-of-concept…
Quantum Computing and Drug Development
Dear reader, in recent years we have witnessed a rapid rise in quantum computing, a technology that represents…